195 original studies of non-coding RNAs in sarcoma

Background: Sarcomas comprise approximately 1% of all human malignancies, and treatment resistance is one of the main reasons for poor prognosis. Accumulating evidence suggests that non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, are important molecules involved in the crosstalk between resistance to chemotherapy, targeted therapy, and radiotherapy via various pathways.
Methods: We searched PubMed (MEDLINE) databases for articles on non-coding RNAs relevant to sarcoma from inception to November 30, 2021. Studies investigating the roles of host-derived microRNAs, long non-coding RNAs, and circular RNAs in sarcoma were included. Data on the roles of ncRNAs in therapeutic regulation and their applicability as biomarkers of sarcomas were extracted. Two independent researchers assessed the quality of the studies using modified guidelines from the Systematic Review Center for Laboratory Animal Experimentation (SYRCLE), a tool based on the Cochrane Collaboration ...